Brynjelsen Sean

President & CEO, DirectorEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4 · filed Aug 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.1M
Net Open-Market Flow
-$6.1M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 20, 2026Sell(S)47K$60.17$2.8M1.0M
Aug 20, 2026Sell(S)36K$61.11$2.2M969K
Aug 20, 2026Sell(S)7K$62.12$456K961K
Aug 19, 2026Sell(S)9K$62.65$562K1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-028651) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.